128 related articles for article (PubMed ID: 9416001)
21. The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development.
Howlett M; Giraud AS; Lescesen H; Jackson CB; Kalantzis A; Van Driel IR; Robb L; Van der Hoek M; Ernst M; Minamoto T; Boussioutas A; Oshima H; Oshima M; Judd LM
Gastroenterology; 2009 Mar; 136(3):967-77. PubMed ID: 19121317
[TBL] [Abstract][Full Text] [Related]
22. A fusion protein of interleukin-11 and soluble interleukin-11 receptor acts as a superagonist on cells expressing gp130.
Pflanz S; Tacken I; Grötzinger J; Jacques Y; Minvielle S; Dahmen H; Heinrich PC; Müller-Newen G
FEBS Lett; 1999 Apr; 450(1-2):117-22. PubMed ID: 10350068
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow culture.
Sammons J; Ahmed N; Khokher MA; Hassan HT
Stem Cells; 2000; 18(3):214-9. PubMed ID: 10840075
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment.
Du XX; Williams DA
Blood; 1994 Apr; 83(8):2023-30. PubMed ID: 7512836
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-11 receptor signaling is required for normal bone remodeling.
Sims NA; Jenkins BJ; Nakamura A; Quinn JM; Li R; Gillespie MT; Ernst M; Robb L; Martin TJ
J Bone Miner Res; 2005 Jul; 20(7):1093-102. PubMed ID: 15940362
[TBL] [Abstract][Full Text] [Related]
26. IL-11 activates human endothelial cells to resist immune-mediated injury.
Mahboubi K; Biedermann BC; Carroll JM; Pober JS
J Immunol; 2000 Apr; 164(7):3837-46. PubMed ID: 10725745
[TBL] [Abstract][Full Text] [Related]
27. [Basic and clinical aspects of IL-6].
Nakajima K; Hirano T
Gan To Kagaku Ryoho; 1991 Apr; 18(4):505-14. PubMed ID: 1707253
[TBL] [Abstract][Full Text] [Related]
28. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
29. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes.
Gabay C; Silacci P; Genin B; Mentha G; Le Coultre C; Guerne PA
Eur J Immunol; 1995 Aug; 25(8):2378-83. PubMed ID: 7545121
[TBL] [Abstract][Full Text] [Related]
30. Production of interleukin-11 in bone-derived endothelial cells and its role in the formation of osteolytic bone metastasis.
Zhang Y; Fujita N; Oh-hara T; Morinaga Y; Nakagawa T; Yamada M; Tsuruo T
Oncogene; 1998 Feb; 16(6):693-703. PubMed ID: 9488033
[TBL] [Abstract][Full Text] [Related]
31. The biology of interleukin 11.
Neben S; Turner K
Stem Cells; 1993 Jul; 11 Suppl 2():156-62. PubMed ID: 8401258
[TBL] [Abstract][Full Text] [Related]
32. [Glucocorticoid and Bone. The effect of glucocorticoid and PTH in osteoblast apoptosis and differentiation via interleukin 11 expression].
Endo I
Clin Calcium; 2014 Sep; 24(9):1321-8. PubMed ID: 25177004
[TBL] [Abstract][Full Text] [Related]
33. gp130 Cytokine family and bone cells.
Heymann D; Rousselle AV
Cytokine; 2000 Oct; 12(10):1455-68. PubMed ID: 11023660
[TBL] [Abstract][Full Text] [Related]
34. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone.
Johnson RW; McGregor NE; Brennan HJ; Crimeen-Irwin B; Poulton IJ; Martin TJ; Sims NA
Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation.
Udagawa N; Horwood NJ; Elliott J; Mackay A; Owens J; Okamura H; Kurimoto M; Chambers TJ; Martin TJ; Gillespie MT
J Exp Med; 1997 Mar; 185(6):1005-12. PubMed ID: 9091574
[TBL] [Abstract][Full Text] [Related]
36. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors.
Kilroy GE; Foster SJ; Wu X; Ruiz J; Sherwood S; Heifetz A; Ludlow JW; Stricker DM; Potiny S; Green P; Halvorsen YD; Cheatham B; Storms RW; Gimble JM
J Cell Physiol; 2007 Sep; 212(3):702-9. PubMed ID: 17477371
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a potent human interleukin-11 agonist.
Harmegnies D; Wang XM; Vandenbussche P; Leon A; Vusio P; Grötzinger J; Jacques Y; Goormaghtigh E; Devreese B; Content J
Biochem J; 2003 Oct; 375(Pt 1):23-32. PubMed ID: 12919066
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.
Morgan H; Tumber A; Hill PA
Int J Cancer; 2004 May; 109(5):653-60. PubMed ID: 14999770
[TBL] [Abstract][Full Text] [Related]
39. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease.
Hoyland JA; Freemont AJ; Sharpe PT
J Bone Miner Res; 1994 Jan; 9(1):75-80. PubMed ID: 8154312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
